Bayer sells diabetes business to Panasonic for 1 bln euros

German pharmaceuticals and chemicals giant Bayer said Wednesday it has agreed to sell its diabetes care business to Panasonic Healthcare Holdings for 1.022 billion euros ($1.2 billion).

"Bayer has entered into a definitive agreement to sell its Diabetes Care business to Panasonic Healthcare Holdings," which is 80-percent owned by US investor KKR and 20-percent by Panasonic Corporation, the German company said in a statement.

The sale covers Bayer's portfolio of blood glucose monitoring meters and strips, as well as lancing devices.

"Closing of the transaction is subject to customary conditions, including relevant antitrust clearance, and is expected to occur in the first quarter of 2016," Bayer said.

Explore further

Merck completes sale of consumer unit to Bayer

© 2015 AFP

Citation: Bayer sells diabetes business to Panasonic for 1 bln euros (2015, June 10) retrieved 24 September 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors